España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Vinod Khosla
Elon Musk Pledges Priority For Tesla Loyalists In Future IPOs, But VC Vinod Khosla Wants Dividends First: 'Reward Long-Term Beliefs'
Meta's Chief AI Scientist Clashes With Early OpenAI Investor Vinod Khosla: 'Clearly...Can Profit Financially From A Closed Source Approach To AI'
Legendary Silicon Valley VC Vinod Khosla Sees Future With Billion Robots Freeing Humans From 'Undesirable Jobs' — Elon Musk Agrees
Meta's Chief AI Scientist Clashes With Early OpenAI Investor Vinod Khosla: 'Clearly...Can Profit Financially From A Closed Source Approach To AI'
Legendary Silicon Valley VC Vinod Khosla Sees Future With Billion Robots Freeing Humans From 'Undesirable Jobs' — Elon Musk Agrees
OpenAI Investor Vinod Khosla Supports TikTok Divestiture, Likens App To 'Programmable Fentanyl' Under CCP Control
Elon Musk's Lawsuit Against OpenAI Seems Like A 'Salve On A Bruised Ego,' Says OpenAI Investor Vinod Khosla
OpenAI Investor Vinod Khosla Supports TikTok Divestiture, Likens App To 'Programmable Fentanyl' Under CCP Control
Elon Musk's Lawsuit Against OpenAI Seems Like A 'Salve On A Bruised Ego,' Says OpenAI Investor Vinod Khosla
'Would You Open Source The Manhattan Project': Vinod Khosla And Marc Andreessen Clash Over Musk's OpenAI Lawsuit
OpenAI Investor Vinod Khosla Ponders About This 'Key Question' As Billionaires Start Wondering About Interest Rate Cuts
Read More...
Vinod Khosla Recent News
OpenAI Investor Vinod Khosla Works 80 Hours A Week, Will Use Peter Thiel's Anti-Aging Methods If They Work
Vinod Khosla says he is still passionate about his work and wants to continue doing so for the next 25 years.
Microsoft, Investors Stand Solidly Behind 'Once In A Generation' CEO Sam Altman, Putting OpenAI Board Under Pressure
OpenAI CEO Sam Altman's sacking has apparently earned the board backlash and backdoor efforts are on to reinstate him, says reports.
Editas Medicine, Backed By Google And Bill Gates, Files $100 Million IPO